Changes in breathomics from a 1-year randomized smoking cessation trial of electronic cigarettes

European Journal of Clinical Investigation

Volumn 46, Issue 8, 2016, Pages 698-706

  Campagna, Davide ^a,b   Cibella, Fabio ^c   Caponnetto, Pasquale ^a,b   Amaradio, Maria Domenica ^b   Caruso, Massimo ^b   Morjaria, Jaymin B ^d   Malerba, Mario ^e   Polosa, Riccardo ^a,b  

^a UNIVERSITY OF CATANIA   (Italy)

^b UNIVERSITY OF CATANIA   (Italy)

^c CNR   (Italy)

^d UNIVERSITY OF HULL   (United Kingdom)

^e UNIVERSITY OF BRESCIA   (Italy)

Author keywords

eCO; electronic cigarette; FeNo; harm reversal; smoking cessation; tobacco harm reduction

Indexed keywords

CARBON MONOXIDE; NICOTINE; NITRIC OXIDE;

ADULT; AGE; ARTICLE; CONCENTRATION (PARAMETERS); ELECTRONIC CIGARETTE; EXPIRED AIR; FEMALE; GENDER; HUMAN; MAJOR CLINICAL STUDY; MALE; PHENOTYPE; PRIORITY JOURNAL; PROSPECTIVE STUDY; SMOKING; SMOKING CESSATION; SPIROMETRY; STUDY DESIGN;

EID: 84979530068     PISSN: 00142972     EISSN: 13652362     Source Type: Journal    
DOI: 10.1111/eci.12651     Document Type: Article

References (36)

1. Caponnetto P, Russo C, Bruno CM, Alamo A, Amaradio MD, Polosa R. Electronic cigarette: a possible substitute for cigarette dependence. Monaldi Arch Chest Dis 2013;79:12–9.
2. Caponnetto P, Maglia M, Polosa R. Electronic cigarettes – from smoking cessation to smoking sensation and back. Addiction 2015;110:678–9.
3. Siegel MB, Tanwar KL, Wood KS. Electronic cigarettes as a smoking-cessation tool: results from an online survey. Am J Prev Med 2011;40:472–5.
4. Farsalinos KE, Romagna G, Tsiapras D, Kyrzopoulos S, Voudris V. Characteristics, perceived side effects and benefits of electronic cigarette use: a worldwide survey of more than 19,000 consumers. Int J Environ Res Public Health 2014;11:4356–73.
5. Biener L, Hargraves JL. A longitudinal study of electronic cigarette use among a population-based sample of adult smokers: association with smoking cessation and motivation to quit. Nicotine Tob Res 2015;17:127–33.
6. Caponnetto P, Campagna D, Cibella F, Morjaria JB, Caruso M, Russo C et al. EffiCiency and Safety of an eLectronic cigAreTte (ECLAT) as tobacco cigarettes substitute: a prospective 12-month randomized control design study. PLoS One 2013;8:e66317.
7. Bullen C, Howe C, Laugesen M, McRobbie H, Parag V, Williman J et al. Electronic cigarettes for smoking cessation: a randomised controlled trial. Lancet 2013;382:1629–37.
8. Rahman MA, Hann N, Wilson A, Mnatzaganian G, Worrall-Carter L. E-cigarettes and smoking cessation: evidence from a systematic review and meta-analysis. PLoS One 2015;10:e0122544.
9. Nathan CF, Hibbs JBJ. Role of nitric oxide synthesis in macrophage antimicrobial activity. Curr Opin Immunol 1991;3:65–70.
10. Alving K, Weitzberg E, Lundberg JM. Increased amount of nitric oxide in exhaled air of asthmatics. Eur Respir J 1993;6:1368–70.
11. Kharitonov SA, Yates D, Robbins RA, Logan-Sinclair R, Shinebourne EA, Barnes PJ. Increased nitric oxide in exhaled air of asthmatic patients. Lancet 1994;343:133–5.
12. Smith AD, Cowan JO, Brassett KP, Herbison GP, Taylor DR. Use of exhaled nitric oxide measurements to guide treatment in chronic asthma. N Engl J Med 2005;352:2163–73.
13. Jarvis MJ, Russell MA, Saloojee Y. Expired air carbon monoxide: a simple breath test of tobacco smoke intake. BMJ 1980;281:484–5.
14. Zhang J, Yao X, Yu R, Bai J, Sun Y, Huang M et al. Exhaled carbon monoxide in asthmatics: a meta-analysis. Respir Res 2010;11:50.
15. Szabo C. Gasotransmitters in cancer: from pathophysiology to experimental therapy. Nat Rev Drug Discov 2016;15:185–203.
16. Kharitonov SA, Robbins RA, Yates D, Keatings V, Barnes PJ. Acute and chronic effects of cigarette smoking on exhaled nitric oxide. Am J Respir Crit Care Med 1995;152:609–12.
17. Robbins RA, Millatmal T, Lassi K, Rennard S, Daughton D. Smoking cessation is associated with an increase in exhaled nitric oxide. Chest 1997;112:313–8.
18. Travers J, Marsh S, Aldington S, Williams M, Shirtcliffe P, Pritchard A et al. Reference ranges for exhaled nitric oxide derived from a random community survey of adults. Am J Respir Crit Care Med 2007;176:238–42.
19. Rengasamy A, Johns RA. Regulation of nitric oxide synthase by nitric oxide. Mol Pharmacol 1993;44:124–8.
20. Moncada S, Higgs A. The L-arginine-nitric oxide pathway. N Engl J Med 1993;329:2002–12.
21. Maziak W, Loukides S, Culpitt S, Sullivan P, Kharitonov SA, Barnes PJ. Exhaled nitric oxide in chronic obstructive pulmonary disease. Am J Respir Crit Care Med 1998;157(3 Pt 1):998–1002.
22. Hogman M, Holmkvist T, Wålinder R, Merilainen P, Ludvıksdottir D, Håkansson L et al. Increased nitric oxide elimination from the airways after smoking cessation. Clin Sci 2002;103:15–9.
23. Louhelainen N, Rytilä P, Haahtela T, Kinnula VL, Djukanović R. Persistence of oxidant and protease burden in the airways after smoking cessation. BMC Pulm Med 2009;9:25.
24. Shiva F, Nasiri M, Sadeghi B, Padyab M. Effects of passive smoking on common respiratory symptoms in young children. Acta Paediatr 2003;92:1394–7.
25. Marini S, Buonanno G, Stabile L, Ficco G. Short-term effects of electronic and tobacco cigarettes on exhaled nitric oxide. Toxicol Appl Pharmacol 2014;278:9–15.
26. Vardavas CI, Anagnostopoulos N, Kougias M, Evangelopoulou V, Connolly GN, Behrakis PK. Short-term pulmonary effects of using an electronic cigarette: impact on respiratory flow resistance, impedance, and exhaled nitric oxide. Chest 2012;141:1400–6.
27. Schober W, Szendrei K, Matzen W, Osiander-Fuchs H, Heitmann D, Schettgen T et al. Use of electronic cigarettes (e-cigarettes) impairs indoor air quality and increases FeNO levels of e-cigarette consumers. Int J Hyg Environ Health 2014;217:628–37.
28. Flouris AD, Chorti MS, Poulianiti KP, Jamurtas AZ, Kostikas K, Tzatzarakis MN et al. Acute impact of active and passive electronic cigarette smoking on serum cotinine and lung function. Inhal Toxicol 2013;25:91–101.
29. Dweik RA, Boggs PB, Erzurum SC, Irvin CG, Leigh MW, Lundberg JO et al. An official ATS clinical practice guideline: interpretation of exhaled nitric oxide levels (FENO) for clinical applications. Am J Respir Crit Care Med 2011;184:602–15.
30. Polosa R, Morjaria J, Caponnetto P, Campagna D, Russo C, Alamo A et al. Effectiveness and tolerability of electronic cigarette in real-life: a 24-month prospective observational study. Intern Emerg Med 2014;9:537–46.
31. Polosa R, Caponnetto P, Maglia M, Morjaria JB, Russo C. Success rates with nicotine personal vaporizers: a prospective 6-month pilot study of smokers not intending to quit. BMC Public Health 2014;14:1159.
32. Vansickel AR, Cobb CO, Weaver MF, Eissenberg TE. A clinical laboratory model for evaluating the acute effects of electronic ‘cigarettes’: nicotine delivery profile and cardiovascular and subjective effects. Cancer Epidemiol Biomarkers Prev 2010;19:1945–53.
33. McRobbie H, Phillips A, Goniewicz ML, Myers Smith K, Knight-West O, Przulj D et al. Effects of switching to electronic cigarettes with and without concurrent smoking on exposure to nicotine, carbon monoxide, and acrolein. Cancer Prev Res 2015;8:873–8.
34. Farsalinos KE, Polosa R. Safety evaluation and risk assessment of electronic cigarettes as tobacco cigarettes substitutes: a systematic review. Ther Adv Drug Saf 2014;5:67–86.
35. Polosa R, Morjaria JB, Caponnetto P, Caruso M, Campagna D, Amaradio MD et al. Persisting long term benefits of smoking abstinence and reduction in asthmatic smokers who have switched to electronic cigarettes. Discov Med 2016;21:99–108.
36. Polosa R. Electronic cigarette use and harm reversal: emerging evidence in the lung. BMC Med 2015;13:54.